Biotech voic­es: Al­ler­gan CEO Saun­ders isn’t slow­ing down on a brisk pace of biotech deal­mak­ing

Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today.

Last year, Al­ler­gan did 12 “step­ping-stone” deals, snap­ping up a whole slate of new de­vel­op­ment pro­grams, ex­pand­ing its pipeline and set­ting the pace as one …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER